2025-07-10 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc. (TGTX), incorporating the provided data. I'll present the numerical data first, followed by analysis.

## TGTX Analysis: TG Therapeutics Inc.

**Company Overview:** TG Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for B-cell malignancies and autoimmune diseases.

**1. Performance vs. S&P 500 (VOO)**

*   **TGTX Cumulative Return:** 67.49%
*   **VOO Cumulative Return:** 94.92%
*   **Absolute Divergence:** -32.3
*   **Relative Divergence:** 15.3 (Indicates TGTX is at the lower end of its historical divergence range compared to VOO)

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha    | Beta   | Cap(B) |
|------------|--------|-------|----------|--------|--------|
| 2015-2017  | -6.0%  | 56.5% | -35.0%   | -0.1   | 1.3    |
| 2016-2018  | -8.0%  | 58.6% | -26.0%   | 0.0    | 0.7    |
| 2017-2019  | 74.0%  | 58.6% | 44.0%    | 0.0    | 1.8    |
| 2018-2020  | 402.0% | 58.6% | 382.0%   | -0.4   | 8.3    |
| 2019-2021  | 125.0% | 63.5% | 76.0%    | -0.5   | 3.0    |
| 2020-2022  | -76.0% | 70.4% | -78.0%   | -0.6   | 1.9    |
| 2021-2023  | -350.0%| 70.4% | -368.0%  | -0.8   | 2.7    |
| 2022-2024  | 71.0%  | 73.1% | 45.0%    | -0.9   | 4.8    |
| 2023-2025  | 74.0%  | 73.1% | 28.0%    | 0.4    | 6.0    |

**Analysis:**

*   TGTX has significantly underperformed the S&P 500 recently, based on the cumulative return difference. The relative divergence being at 15.3 suggests this underperformance is near the lower end of its historical range.
*   The Alpha/Beta analysis reveals very volatile performance. Some periods show extremely high alpha (outperformance relative to the market), while others show significant underperformance. The beta values are generally low, but fluctuate significantly.
*   The CAGR and MDD figures highlight the high-risk, high-reward nature of this stock, typical of the biotechnology sector.

**2. Recent Price Action**

*   **Current Price:** 37.71
*   **Previous Close:** 35.61
*   **Change:** 5.9 (Significant positive change)
*   **5-Day Moving Average:** 36.42
*   **20-Day Moving Average:** 36.83
*   **60-Day Moving Average:** 37.12

**Analysis:**

*   The stock price has recently experienced a substantial increase. The current price is above all three moving averages, suggesting a short-term upward trend.

**3. Market Risk Indicators and Expected Return**

*   **MRI:** 0.3373 (Low Risk)
*   **RSI:** 60.4 (Approaching overbought territory)
*   **PPO:** 0.0926 (Positive momentum)
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (46 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** -1.7 (Short-term decline in relative performance)
*   **Expected Return (vs. S&P 500):** -256.7% (Long-term, negative expected outperformance)

**Analysis:**

*   The Market Risk Indicator (MRI) suggests a low-risk environment.
*   The RSI suggests the stock is approaching overbought conditions.
*   The PPO indicates positive momentum.
*   The Hybrid Signal suggests a cautious buy signal, with a recommendation to buy 80% of available cash.
*   The negative expected return suggests that, based on the model, long-term investment in TGTX may underperform the S&P 500.

**4. Recent News & Significant Events**

*   **[2025-07-10]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-06]:** Analyst discussions of recent performance in the context of industry trends and global economic factors.
*   **[2025-07-08]:** Notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-09]:** Market experts highlighting both risks and opportunities.

**Analysis:**

*   The recent news items indicate that TGTX is experiencing significant developments, potentially impacting its stock price. Volatility is noted, and investors are advised to monitor news and company announcements.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출   |
|------------|--------|--------|
| 2025-05-09  | 0.03   | 0.12 B$  |
| 2024-11-07  | 0.03   | 0.08 B$  |
| 2024-08-09  | 0.05   | 0.07 B$  |
| 2024-05-06  | -0.07  | 0.06 B$  |
| 2025-05-09  | -0.07  | 0.06 B$  |

**Analysis:**

*   The recent earnings data shows a trend of improving revenue and recently positive EPS, although with some past losses. The most recent quarter shows a positive EPS and higher revenue, which could be a factor in the recent price surge.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.12B  | 87.14%        |
| 2024-12-31 | $0.11B  | 85.77%        |
| 2024-09-30 | $0.08B  | 88.86%        |
| 2024-06-30 | $0.07B  | 88.70%        |
| 2024-03-31 | $0.06B  | 91.43%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | $0.24B  | 2.13%   |
| 2024-12-31 | $0.22B  | 10.49%  |
| 2024-09-30 | $0.19B  | 2.02%   |
| 2024-06-30 | $0.18B  | 3.87%   |
| 2024-03-31 | $0.16B  | -6.69%  |

**Analysis:**

*   Revenue has been steadily increasing. Profit margins are very high, suggesting strong pricing power or cost control.
*   Equity is also increasing, indicating a strengthening financial position.
*   ROE has fluctuated, with a recent decline, but overall shows some positive trends.

**7. 종합 Analysis (Overall Summary)**

TGTX presents a mixed picture. Here's a breakdown:

*   **Positive Signals:**
    *   Recent positive price momentum and a substantial single-day price increase.
    *   Increasing revenue and high-profit margins.
    *   Improving equity.
    *   Low Market Risk Indicator (MRI).
    *   Recently positive EPS.
*   **Negative Signals:**
    *   Significant underperformance relative to the S&P 500, based on cumulative returns.
    *   Negative expected return relative to the S&P 500, based on the model's long-term outlook.
    *   High volatility and risk profile, as shown by the alpha/beta analysis and MDD figures.
    *   Short-term decline in relative performance
*   **Neutral Signals:**
    *   Recent news suggests significant developments that could impact the stock in either a positive or negative way.

**Conclusion:**

TGTX appears to be a high-risk, high-reward investment. The recent positive price action and improving financials are encouraging, but the significant underperformance relative to the market and the model's negative long-term outlook should give investors pause. The stock's price is above Moving averages which shows that this may be a short term rise. Investors should closely monitor company news and industry developments.
